Free Disclosure Statement - District Court of Delaware - Delaware

Case 1 :06-cv-00741-SLR Document 3 Filed 12/06/2006 Page 1 of 1 - _
IN THE UNITED STATES DISTRICT COURT
POR THE DISTRICT OF DELAWARE E
)
CIZLGENE CORPORATION, NOVARTIS )
PHARMACEUTICALS CORPORATION and )
NOVARTIS PHARMA AG, ) Civil Action No.
)
Plaintiffs, ) i
) i
v. )
)
ABRIKA PHARMACEUTICALS, INC. and ) I .
ABRIKA PHARMACEUTICAL, LLLP, ) g
)
_ Defendants. )
FED. R. CIV. P. 7.1 DISCLOSURE STATEMENT
Pursuant to Federal Rule of Civil Procedure 7. l(a), Plaintiffs Novartis Pharmaceuticals
Corporation and Novartis Pharma AG disclose that they are either direct or indirect wholly—
owned subsidiaries of Novartis AG, which is a publicly held company.
POTTER ANDERSON & CORROON LLP
OF COUNSEL:
Robert L. Baechtold
Henry J. Renk By; I A I gif
Nicholas N. Kailas Philip A. Rovne1·(#3215)
FITZPATRICK, CELLA, HARPER & HQIQUECS Pfgza
SCINTO P. O. Box 951
30 Rockefeller Plaza Wilmington, Delaware 19899
New York, New York 10112 (302) 984—6000
(212) 218-2lOO p1·[email protected]
‘ Dated: D€C€H1b€1` 6, 2006 Attgryieygfgr Plaintiff;
765770 Novartis Pharmaceuticals Corporation
and Novartis Pharma AG